AnalystBook Research · Company Intelligence

Arq, Inc.

ARQNasdaq

Built from Arq, Inc.'s own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

Arq's net loss widened to $52.6M and cash from ops turned negative, but capex cuts improved free cash flow.

The read at a glance✓ Audited against SEC data
  • Business mixActivated carbon consumablesNote
  • RevenueTagged consumables revenue $103.0MNote
  • ProfitabilityNet loss widened to $52.6MWatch
  • CashFCF improved to -$11.3MNote
  • Balance sheetDebt up; equity downWatch
  • Insiders9 buys / 5 sells; cluster buyOK
  • AccountingFY2021 Beneish flag; EQ greyWatch

Business

Arq sells activated carbon consumables used to purify contaminated liquid, soil, and gas streams across industrial end markets.

Leadership changes

From Arq, Inc.'s own filings, the day they're filed.

  • Peter Owino · Chief Accounting Officer · appointmenteff. 2026-06-12
  • Stacia Hansen · Chief Accounting Officer · departureeff. 2026-06-12
  • Shimon Steinmetz · President · appointmenteff. 2026-05-26

Latest filings

  • 8-K · Company announcement2026-08-28
  • 10-Q · Quarterly report2026-08-10
  • 8-K · Company announcement2026-08-10
  • 8-K · Company announcement2026-07-23
  • 8-K · Company announcement2026-07-02
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • Main tension🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about Arq, Inc., every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.